CPMV
Price
$0.60
Change
-$0.27 (-31.03%)
Updated
Nov 13 closing price
Capitalization
4.35M
Intraday BUY SELL Signals
SIGY
Price
$2.00
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Capitalization
3.21M
Intraday BUY SELL Signals
Interact to see
Advertisement

CPMV vs SIGY

Header iconCPMV vs SIGY Comparison
Open Charts CPMV vs SIGYBanner chart's image
Mosaic ImmunoEngineering
Price$0.60
Change-$0.27 (-31.03%)
Volume$122
Capitalization4.35M
Sigyn Therapeutics
Price$2.00
Change-$0.00 (-0.00%)
Volume$154
Capitalization3.21M
CPMV vs SIGY Comparison Chart in %
CPMV
Daily Signal:
Gain/Loss:
SIGY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CPMV vs. SIGY commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPMV is a Hold and SIGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (CPMV: $0.60 vs. SIGY: $2.00)
Brand notoriety: CPMV and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPMV: 7% vs. SIGY: 16%
Market capitalization -- CPMV: $4.35M vs. SIGY: $3.21M
CPMV [@Biotechnology] is valued at $4.35M. SIGY’s [@Biotechnology] market capitalization is $3.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPMV’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • CPMV’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, CPMV is a better buy in the long-term than SIGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPMV’s TA Score shows that 4 TA indicator(s) are bullish while SIGY’s TA Score has 4 bullish TA indicator(s).

  • CPMV’s TA Score: 4 bullish, 4 bearish.
  • SIGY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SIGY is a better buy in the short-term than CPMV.

Price Growth

CPMV (@Biotechnology) experienced а -30.88% price change this week, while SIGY (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPMV($4.35M) has a higher market cap than SIGY($3.21M). CPMV YTD gains are higher at: -14.432 vs. SIGY (-36.508). CPMV has higher annual earnings (EBITDA): -604.21K vs. SIGY (-2.39M). CPMV has more cash in the bank: 53.6K vs. SIGY (12.9K). CPMV has less debt than SIGY: CPMV (1.63M) vs SIGY (2.51M). CPMV (0) and SIGY (0) have equivalent revenues.
CPMVSIGYCPMV / SIGY
Capitalization4.35M3.21M135%
EBITDA-604.21K-2.39M25%
Gain YTD-14.432-36.50840%
P/E RatioN/AN/A-
Revenue00-
Total Cash53.6K12.9K416%
Total Debt1.63M2.51M65%
FUNDAMENTALS RATINGS
CPMV vs SIGY: Fundamental Ratings
CPMV
SIGY
OUTLOOK RATING
1..100
1118
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6586
P/E GROWTH RATING
1..100
4698
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGY's Valuation (78) in the null industry is in the same range as CPMV (89). This means that SIGY’s stock grew similarly to CPMV’s over the last 12 months.

SIGY's Profit vs Risk Rating (100) in the null industry is in the same range as CPMV (100). This means that SIGY’s stock grew similarly to CPMV’s over the last 12 months.

SIGY's SMR Rating (100) in the null industry is in the same range as CPMV (100). This means that SIGY’s stock grew similarly to CPMV’s over the last 12 months.

CPMV's Price Growth Rating (65) in the null industry is in the same range as SIGY (86). This means that CPMV’s stock grew similarly to SIGY’s over the last 12 months.

CPMV's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for SIGY (98). This means that CPMV’s stock grew somewhat faster than SIGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPMVSIGY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
50%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CPMV
Daily Signal:
Gain/Loss:
SIGY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HURA1.920.04
+2.13%
TuHURA Biosciences Inc
CURB23.310.19
+0.82%
Curbline Properties Corp
BWXT175.91-0.27
-0.15%
BWX Technologies
CNET1.89-0.01
-0.77%
ZW Data Action Technologies Inc
IDR33.98-1.70
-4.76%
Idaho Strategic Resources

CPMV and

Correlation & Price change

A.I.dvisor tells us that CPMV and RANI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPMV and RANI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPMV
1D Price
Change %
CPMV100%
N/A
RANI - CPMV
23%
Poorly correlated
-3.09%
AKESF - CPMV
22%
Poorly correlated
-9.83%
PPTDF - CPMV
21%
Poorly correlated
N/A
SIGY - CPMV
6%
Poorly correlated
N/A
HLOSF - CPMV
5%
Poorly correlated
N/A
More

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and OTLK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
N/A
OTLK - SIGY
23%
Poorly correlated
+7.34%
ACHV - SIGY
21%
Poorly correlated
-2.05%
KALA - SIGY
21%
Poorly correlated
-1.46%
CSPHF - SIGY
8%
Poorly correlated
N/A
CPMV - SIGY
6%
Poorly correlated
N/A
More